| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $12.6B | $11.3B | $10.0B | $6.6B | $9.6B | $2.7B | $2.2B | $0.7B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $2.4B | $2.3B | $1.8B | $-0.5B | $2.9B | $1.0B | $0.6B | $-0.5B |
| EPS (Basic) | $15.32 | $14.65 | $11.74 | $-3.06 | $18.29 | $6.52 | $3.84 | $-2.78 |
| EPS (Diluted) | $15.17 | $14.53 | $11.66 | $-3.06 | $18.10 | $6.47 | $3.79 | $-2.78 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $41.0B | $36.5B | $32.8B | $29.7B | $31.4B | $27.5B | $25.4B | $21.9B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | — | — | — | — | $1.1B | $0.9B | $0.8B | $0.8B |
| Total Liabilities | $25.1B | $22.6B | $20.7B | $19.2B | $18.3B | $16.8B | $15.5B | $14.1B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $15.9B | $13.9B | $12.1B | $10.5B | $13.1B | $10.8B | $9.9B | $7.8B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $3.1B | $2.6B | $2.1B | $2.1B | $2.0B | $1.5B | $1.2B | $1.2B |
| Investing Cash Flow | $-1.7B | $-1.7B | $-1.6B | $-0.9B | $-1.1B | $-0.6B | $-0.7B | $-0.5B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $-1.0B | $-0.9B | $-0.8B | $-1.0B | $-0.7B | $-0.8B | $-0.5B | $-0.6B |